Wasim Hanif
About
Wasim Hanif is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and General Health Professions.
According to data from OpenAlex, Wasim Hanif has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Physiology and 11 papers in General Health Professions. Recurrent topics in Wasim Hanif's work include Dietary Effects on Health (15 papers), Diabetes Treatment and Management (10 papers) and Diabetes Management and Education (6 papers). Wasim Hanif is often cited by papers focused on Dietary Effects on Health (15 papers), Diabetes Treatment and Management (10 papers) and Diabetes Management and Education (6 papers). Wasim Hanif collaborates with scholars based in United Kingdom, United Arab Emirates and United States. Wasim Hanif's co-authors include Kamlesh Khunti, Kiran Patel, Daniel Pan, Jatinder S. Minhas, Shirley Sze, Mansoor N. Bangash, Iain Squire, Laura B Nellums, Manish Pareek and Caroline Williams and has published in prestigious journals such as The Lancet, Diabetes Care and BMJ.
In The Last Decade
Wasim Hanif
49 papers receiving 1.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Wasim Hanif United Kingdom | 21 | 814 | 548 | 228 | 159 | 152 | 51 | 1.8k | ||
| Sophie V. Eastwood United Kingdom | 20 | 421 0.5× | 566 1.0× | 95 0.4× | 26 0.2× | 369 2.4× | 39 | 1.7k | ||
| Churchill Lukwiya Onen Botswana | 6 | 653 0.8× | 785 1.4× | 24 0.1× | 50 0.3× | 160 1.1× | 7 | 2.6k | ||
| Neil T. Raymond United Kingdom | 29 | 466 0.6× | 849 1.5× | 28 0.1× | 209 1.3× | 193 1.3× | 58 | 2.3k | ||
| Heejin Kimm South Korea | 22 | 403 0.5× | 284 0.5× | 52 0.2× | 57 0.4× | 169 1.1× | 86 | 1.9k | ||
| Paul Rheeder South Africa | 24 | 214 0.3× | 745 1.4× | 130 0.6× | 26 0.2× | 189 1.2× | 120 | 2.0k | ||
| Helen Booth United Kingdom | 22 | 681 0.8× | 131 0.2× | 37 0.2× | 24 0.2× | 145 1.0× | 41 | 1.9k | ||
| Christina M. Parrinello United States | 19 | 186 0.2× | 502 0.9× | 91 0.4× | 12 0.1× | 139 0.9× | 48 | 1.8k | ||
| Patricia Montague Canada | 6 | 196 0.2× | 410 0.7× | 54 0.2× | 22 0.1× | 269 1.8× | 9 | 1.8k | ||
| Kimberly K. Vesco United States | 27 | 85 0.1× | 622 1.1× | 50 0.2× | 41 0.3× | 167 1.1× | 85 | 2.8k | ||
| Øystein Karlstad Norway | 25 | 204 0.3× | 130 0.2× | 303 1.3× | 19 0.1× | 75 0.5× | 81 | 2.0k |
Countries citing papers authored by Wasim Hanif
Since
Specialization
Citations
This map shows the geographic impact of Wasim Hanif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wasim Hanif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wasim Hanif more than expected).
Fields of papers citing papers by Wasim Hanif
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Wasim Hanif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wasim Hanif. The network helps show where Wasim Hanif may publish in the future.
Co-authorship network of co-authors of Wasim Hanif
This figure shows the co-authorship network connecting the top 25 collaborators of Wasim Hanif. A scholar is included among the top collaborators of Wasim Hanif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wasim Hanif. Wasim Hanif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mostafa, Samiul, Wasim Hanif, Francesca L. Crowe, et al.. (2025). The effect of non-pharmacological sleep interventions on glycaemic measures in adults with sleep disturbances and behaviours: A systematic review and meta-analysis. Diabetes and Vascular Disease Research. 22(1). 1507150055–1507150055.
2.
Sunkersing, David, Manoj Mistry, Wasim Hanif, et al.. (2025). Recommendations for improving accessibility of digital health interventions for cardiometabolic disease for ethnically diverse populations. Digital Health. 11. 599916312–599916312.
3.
Agha, Adnan, et al.. (2024). Burnout among diabetes specialist registrars across the United Kingdom in the post-pandemic era. Frontiers in Medicine. 11. 1367103–1367103.
4.
Phillips, Katherine W., Jonathan Hazlehurst, Srikanth Bellary, et al.. (2023). Inequalities in the management of diabetic kidney disease in UK primary care: A cross‐sectional analysis of a large primary care database. Diabetic Medicine. 41(1). e15153–e15153.
5.
Poole, Lydia, Harpreet Sood, Fiona Stevenson, et al.. (2023). Digital health, cardiometabolic disease and ethnicity: an analysis of United Kingdom government policies from 2010 to 2022. Journal of Public Health Policy. 44(2). 179–195.
6.
Singhal, Rishi, Victor Roth Cardoso, Tom Wiggins, et al.. (2023). Safety outcomes of bariatric surgery in patients with advanced organ disease: the ONWARD study: a prospective cohort study. International Journal of Surgery. 110(1). 95–110.
7.
Agha, Adnan, et al.. (2022). Burnout in diabetes and endocrinology specialist registrars across England, Scotland and Wales in the pre-COVID era. Primary care diabetes. 16(4). 515–518.
8.
Poole, Lydia, Wasim Hanif, Kamlesh Khunti, et al.. (2022). The Use of Digital Health Interventions for Cardiometabolic Diseases Among South Asian and Black Minority Ethnic Groups: Realist Review. Journal of Medical Internet Research. 25. e40630–e40630.
9.
Kempegowda, Punith, Eka Melson, Lucretia Thomas, et al.. (2021). Differences in presentation, severity and management of DKA in type 1 and type 2 diabetes during the COVID-19 pandemic. Clinical Medicine. 21(2). 1–2.
10.
Antza, Christina, et al.. (2020). Mobile Clinical Decision Support System for the Management of Diabetic Patients With Kidney Complications in UK Primary Care Settings: Mixed Methods Feasibility Study. JMIR Diabetes. 5(4). e19650–e19650.
11.
Hanif, Wasim, Vinod Patel, Samina Ali, et al.. (2020). The South Asian Health Foundation (UK) guidelines for managing diabetes during Ramadan. Diabetes Research and Clinical Practice. 164. 108145–108145.
12.
Khunti, Kamlesh, Ash Routen, Kiran Patel, et al.. (2020). Focused action is required to protect ethnic minority populations from COVID-19 post-lockdown. British Journal of General Practice. 71(702). 37–40.
13.
Levene, Louis S, Briana Coles, Melanie J. Davies, et al.. (2020). COVID-19 cumulative mortality rates for frontline healthcare staff in England. British Journal of General Practice. 70(696). 327.2–328.
14.
Pan, Daniel, Shirley Sze, Jatinder S. Minhas, et al.. (2020). The impact of ethnicity on clinical outcomes in COVID-19: A systematic review. EClinicalMedicine. 23. 100404–100404.
15.
Sahay, Rakesh, Khadija Hafidh, Mathieu Coudert, et al.. (2020). Safety of lixisenatide plus basal insulin treatment regimen in Indian people with type 2 diabetes mellitus during Ramadan fast: A post hoc analysis of the LixiRam randomized trial. Diabetes Research and Clinical Practice. 163. 108148–108148.
16.
Susarla, Radhika, Kamlesh Khunti, Muhammad Ali Karamat, et al.. (2019). The effect of Ramadan fasting on cardiovascular events and risk factors in patients with type 2 diabetes: A systematic review. Diabetes Research and Clinical Practice. 159. 107918–107918.
17.
Hassanein, Mohamed, Rakesh Sahay, Khadija Hafidh, et al.. (2019). Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial. Diabetes Research and Clinical Practice. 150. 331–341.
18.
Hassanein, Mohamed, Monira Alarouj, Osama Hamdy, et al.. (2017). Diabetes and Ramadan: Practical guidelines. Diabetes Research and Clinical Practice. 126. 303–316.
19.
Khunti, Kamlesh, Srikanth Bellary, Muhammad Ali Karamat, et al.. (2016). Representation of people of South Asian origin in cardiovascular outcome trials of glucose‐lowering therapies in Type 2 diabetes. Diabetic Medicine. 34(1). 64–68.
20.
Hassanein, Mohamed, et al.. (2011). Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study. Current Medical Research and Opinion. 27(7). 1367–1374.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sophie V. Eastwood Breakdown of academic impact, for papers by Churchill Lukwiya Onen Breakdown of academic impact, for papers by Neil T. Raymond Breakdown of academic impact, for papers by Heejin Kimm Breakdown of academic impact, for papers by Paul Rheeder Breakdown of academic impact, for papers by Helen Booth Breakdown of academic impact, for papers by Christina M. Parrinello Breakdown of academic impact, for papers by Patricia Montague Breakdown of academic impact, for papers by Kimberly K. Vesco Breakdown of academic impact, for papers by Øystein Karlstad